Metal-based Nanoparticles in the Treatment of Infectious Diseases

被引:0
作者
Kumbhar, Popat [1 ]
Patil, Onkar [1 ]
Karade, Preeti [2 ]
Bhokare, Rajdeep [1 ]
Gupta, Gaurav [3 ,4 ]
Singh, Sachin Kumar [5 ,6 ]
Dua, Kamal [6 ,7 ]
Disouza, John [1 ]
Patravale, Vandana [8 ]
机构
[1] Tatyasaheb Kore College of Pharmacy, Warananagar, Tal: Panhala, Dist: Kolhapur Maharashtra
[2] Appasaheb Birnale College of Pharmacy, Maharashtra, Sangli
[3] School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur
[4] School of Pharmacy, Graphic Era Hill University, Dehradun
[5] School of Pharmaceutical Sciences, Lovely Professional University, Punjab, Phagwara
[6] Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, 2007, NSW
[7] Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, 2007, NSW
[8] Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Maharashtra, Mumbai
关键词
antibiotics; Emerging infectious diseases; Infectious diseases; metal-based nanoparticles; multi-drug resistance; synthesis techniques;
D O I
10.2174/2210681213666230912144049
中图分类号
学科分类号
摘要
Infectious diseases caused by different pathogens are responsible for high mortality across the globe. Multi-drug resistance (MDR) of microorganisms towards different antibiotics has posed a great challenge in treating infectious diseases efficiently. The metal-based nanoparticles (MNPs) have demonstrated great promise in treating infectious diseases because of their inherent antimicrobial potential. Besides, these NPs show site-specific delivery of antibiotic therapeutics, thereby minimizing dose, dose frequency, and side effects. Further, the synergistic effect of MNPs with an antibiotic can reduce the MDR. However, the fabrication of MNPs using an apt fabrication technique with proper control of charge, size, and morphology is highly required to achieve better therapeutic performance. This review focuses on MNPs as a potential avenue to treat infectious diseases. The role of MNPs in combating MDR, different sorts of MNPs, and their fabrication techniques are discussed. Furthermore, assorted types of MNPs employed in antibiotic delivery to treat infectious diseases are discussed with manifold case studies. In short, MNPs alone or as a carrier of antibiotics seems to be an effective strategy in wiping out infectious diseases. © 2024 Bentham Science Publishers.
引用
收藏
页码:69 / 78
页数:9
相关论文
共 75 条
  • [1] Fauci A.S., Morens D.M., The perpetual challenge of infectious diseases, N. Engl. J. Med, 366, 5, pp. 454-461, (2012)
  • [2] Parrish C.R., Holmes E.C., Morens D.M., Park E.C., Burke D.S., Calisher C.H., Laughlin C.A., Saif L.J., Daszak P., Crossspecies virus transmission and the emergence of new epidemic diseases, Microbiol. Mol. Biol. Rev, 72, 3, pp. 457-470, (2008)
  • [3] World health statistics 2022
  • [4] Gu J., Zhou Z., Wang Y., Editorial: Evolutionary mechanisms of infectious diseases, Front. Microbiol, 12, (2021)
  • [5] Ismail B., Shafei M.N., Harun A., Ali S., Omar M., Deris Z.Z., Predictors of polymyxin B treatment failure in Gram-negative healthcare-associated infections among critically ill patients, J. Microbiol. Immunol. Infect, 51, 6, pp. 763-769, (2018)
  • [6] Lee N.Y., Ko W.C., Hsueh P.R., Nanoparticles in the treatment of infections caused by multidrug-resistant organisms, Front. Pharmacol, 10, (2019)
  • [7] Ammons M., Anti-biofilm strategies and the need for innovations in wound care, Recent Patents Anti-Infect. Drug Disc, 5, 1, pp. 10-17, (2010)
  • [8] Ribet D., Cossart P., How bacterial pathogens colonize their hosts and invade deeper tissues, Microbes Infect, 17, 3, pp. 173-183, (2015)
  • [9] Slavin Y.N., Asnis J., Hafeli U.O., Bach H., Metal nanoparticles: Understanding the mechanisms behind antibacterial activity, J. Nanobiotechnology, 15, 1, (2017)
  • [10] Munita J. M., Arias C. A., Mechanisms of antibiotic resistance, Microbiol. Spectrum, 4, pp. 0016-2015, (2016)